Updates from The Motley Fool

Latest updates on Revance Therapeutics, Inc from Fool.com.

Stock Performance

RVNC vs. S&P 500 | 2 Year Performance
RVNC 1-Day Stock Chart
RVNC 5-Day Stock Chart
RVNC 1-Month Stock Chart
RVNC 3-Month Stock Chart
RVNC 6-Month Stock Chart
RVNC 1-Year Stock Chart
RVNC 2-Year Stock Chart
RVNC 5-Year Stock Chart
View Interactive RVNC Charts
Sponsored by

Key Data Points

Primary metrics and data points about Revance Therapeutics, Inc.
Current Price: $19.83
Prev Close: $19.58
Open: $19.56
Bid: $15.19
Ask: $0.00
Day's Range: $19.35 - $20.00
52wk Range: $15.41 - $42.41
Volume: 192,790
Avg Vol 178,011
Market Cap: $556.47M
P/E (ttm): -6.36
EPS (ttm): -$3.08
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Revance Therapeutics, Inc.
CAPS Rating 3 out of 5
16 Outperform
2 Underperform
CAPS All Stars
6 Outperform
2 Underperform

How do you think Revance Therapeutics, Inc will perform against the market?

You pick for Revance Therapeutics, Inc is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Revance Therapeutics, Inc.

Revance Therapeutics, Inc

  • Exchange: NASDAQ